Full Text View
Tabular View
No Study Results Posted
Related Studies
Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD
This study has been completed.
Study NCT00065728   Information provided by Alcon Research
First Received: July 31, 2003   Last Updated: May 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
Anecortave Acetate
Sponsors listed in this trial
Alcon Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services